WHO Immunization Implementation Guide
0.2.0 - ci-build

WHO Immunization Implementation Guide, published by WHO. This guide is not an authorized publication; it is the continuous build for version 0.2.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/WorldHealthOrganization/smart-immunizations/ and changes regularly. See the Directory of published versions

PlanDefinition: IMMZ.D2.DT.Measles Ongoing Transmission

Official URL: http://smart.who.int/immunizations/PlanDefinition/IMMZD2DTMeaslesOngoingTx Version: 0.2.0
Draft as of 2025-11-10 Computable Name: IMMZD2DTMeaslesOngoingTx

Countries with ongoing transmission in which the risk of measles mortality remains high (countries that provide first dose of measles-containing vaccine (MCV) at 9 months and second dose of MCV at 15 months)

Id: IMMZD2DTMeaslesOngoingTx
Url: IMMZ.D2.DT.Measles Ongoing Transmission
Version: 0.2.0
Title: IMMZ.D2.DT.Measles Ongoing Transmission
Status: draft
Type:

system: http://terminology.hl7.org/CodeSystem/plan-definition-type

code: eca-rule

Date: 2025-11-10 23:31:43+0000
Publisher: WHO
Description:

Countries with ongoing transmission in which the risk of measles mortality remains high (countries that provide first dose of measles-containing vaccine (MCV) at 9 months and second dose of MCV at 15 months)
Knowledge Capability: computable
Related Artifacts:

References

  • ​

    WHO recommendations for routine immunization - summary tables (January 2025)
Libraries:
IMMZD2DTMeaslesOngoingTxLogic
Actions:
Determine if the client is due for MCV1 in countries with ongoing transmission.: Determine if the client is due for measles vaccination MCV1 according to the national immunization protocol. Countries with ongoing transmission in which the risk of measles mortality remains high.
If: Applicability: Client is due for MCV1 (Client is due for MCV1)
Then: Definition: IMMZD2DTMR
Dynamic Values:
status: ('draft')
intent: ('proposal')
medication: (Concept { codes: { Code { system: 'http://smart.who.int/immunizations/CodeSystem/IMMZ.Z', code: 'DE9', display: 'Measles-containing vaccines' } }, display: 'Measles-containing vaccines' })
Determine if the client is due for MCV2 in countries with ongoing transmission.: Determine if the client is due for measles vaccination MCV2 according to the national immunization protocol. Countries with ongoing transmission in which the risk of measles mortality remains high.
If: Applicability: Client is due for MCV2 (Client is due for MCV2)
Then: Definition: IMMZD2DTMR
Dynamic Values:
status: ('draft')
intent: ('proposal')
medication: (Concept { codes: { Code { system: 'http://smart.who.int/immunizations/CodeSystem/IMMZ.Z', code: 'DE9', display: 'Measles-containing vaccines' } }, display: 'Measles-containing vaccines' })
Send Guidance for the patient regarding MCV primary series.: Send Guidance for the patient regarding MCV primary series.
If: Applicability: Has Guidance (Has Guidance)
Then: Definition: IMMZ.D2.DT.CR
Dynamic Values:
status: ('active')
payload.contentString: (Guidance)
category.coding: (Code { system: 'http://terminology.hl7.org/CodeSystem/communication-category', code: 'alert' })
priority: (Code { system: 'http://hl7.org/fhir/request-priority', code: 'routine' })